Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Airport Retailers Can Now Charge an Employee Benefits Fee—but It May Not Go to Workers
Georgia Fearn, Inc.com
CATrends: False HEPA Claims
Lawsuits attempt to clear the air.
Olive Tree People
These “waterless” beauty products contain some surprising ingredients.
The Struggle is (Not) Real
Rags-to-riches stories on repeat.
Giant Bicycles’ ‘Shipping Fee’
TINA.org finds bike maker peddling misleading online prices.